ZYMAXID

Pays: Israël

Langue: anglais

Source: Ministry of Health

Ingrédients actifs:

GATIFLOXACIN 0.5 %W/V

Disponible depuis:

ALLERGAN ISRAEL LTD

Code ATC:

S01AX21

forme pharmaceutique:

OPHTHALMIC SOLUTION

Mode d'administration:

OCULAR

Fabriqué par:

ALLERGAN INC., USA

Groupe thérapeutique:

GATIFLOXACIN

indications thérapeutiques:

Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.

Date de l'autorisation:

2012-11-01